Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Compugen Ltd (NASDAQ:CGEN)

6.82
Delayed Data
As of 3:59pm ET
 -0.18 / -2.57%
Today’s Change
4.32
Today|||52-Week Range
7.98
+6.73%
Year-to-Date
No recent news for Compugen Ltd.

Today’s Trading

Previous close7.00
Today’s open6.95
Day’s range6.79 - 6.95
Volume87,018
Average volume (3 months)121,156
Market cap$354.0M
Dividend yield--
Data as of 3:59pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)-73.91%
Earnings growth (this year)-66.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-24.99%
P/E ratioNM
Price/Sales34.74
Price/Book3.94

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...-0.05-0.32%
VYGRVoyager Therapeutics...+0.02+0.16%
AGENAgenus Inc+0.05+1.30%
NDRMNeuroderm Ltd+0.25+1.40%
Data as of 3:59pm ET, 05/26/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$9.3M
Annual profit (last year)-$20.2M
Net profit margin-217.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Anat Cohen-Dayag
Chief Financial Officer
Ari Krashin
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers

Search for Jobs